Key takeaways

Kimberly-Clark (KMB) stock rose 5.4% on Monday, April 22, after the company released stronger-than-expected first-quarter results. Higher pricing and a favorable mix helped Kimberly-Clark to beat analysts’ sales estimate. Meanwhile, improved organic sales and share repurchases supported the earnings beat. However, both sales and earnings fell on a YoY basis in the first quarter, reflecting adverse currency rates, a volume decline, and a higher effective tax rate.

Kimberly-Clark Stock Rose on Stronger-Than-Expected Q1 Results

Ready to put your morning scrolling to use? Sign up for Bagels & Stox, our witty take on the top market and investment news straight to your inbox! Whether you’re a serious investor or just want to be informed, Bagels & Stox will be your favorite email.

We expect currency volatility and inflation in raw and packaging material costs to limit the top and bottom lines of other major CPG (consumer packaged goods) companies including Procter & Gamble (PG), Colgate-Palmolive (CL), Church & Dwight (CHD), and Clorox (CLX). However, higher pricing, innovation, and cost savings are expected to support organic sales and earnings.

We expect Kimberly-Clark’s sales and earnings to improve gradually in the second half of 2019, driven by an increase in pricing, premium innovation, and share buybacks. However, sales and profits are likely to remain pressured in the near term, reflecting weakness in volumes, adverse currency rates, and higher tax.

Stock performance

Including yesterday’s gain, Kimberly-Clark stock is now up 14.3% on a YTD basis as of April 22. Meanwhile, Colgate-Palmolive, Procter & Gamble, and Church & Dwight have risen 16.9%, 15.3%, and 12.2%, respectively. However, Clorox stock is trading roughly flat, reflecting pressure on sales.

In comparison, the S&P 500 has risen by 16.0% so far this year.

Latest articles

This year, Pfizer (PFE) stock has fallen 0.34% and Bristol-Myers Squibb (BMY) stock has fallen 6.48%. Both companies are focused on strengthening their position in the high-growth oncology and immunology markets. Let's take a closer look at each.

Walt Disney’s (DIS) latest movie, Toy Story 4, has reportedly broken records in the opening weekend with $118 million in sales. However, the opening weekend collection was behind analysts’ expectations of at least $150 million in the first weekend.

24 Jun

Will Home Depot’s Upward Momentum to Continue?

WRITTEN BY Rajiv Nanjapla

As of June 21, Home Depot (HD) was trading at $209.39, which implies a rise of 9.7% since the announcement of its first-quarter earnings on May 21. Also, the company was trading at a premium of 32.4% from its 52-week low of $158.09 and a discount of 2.8% from its 52-week high of $215.43.

On June 21, Aurora Cannabis (ACB) made an announcement that indicated that it will move towards higher margin vape products. In addition, the company also believes concentrates and edibles will command higher margins. In anticipation of this development, the company announced the expansion of its facility to capitalize on growth related to these segments.

Shares of Mondelēz International (MDLZ) are scaling new heights thanks to its stellar gains so far this year. Mondelēz stock is up 38.0% on a YTD (year-to-date) basis, and it closed at $55.25—just a shade lower than its 52-week high of $55.71—on June 21.

24 Jun

How Long Will Facebook's Libra Fuel Bitcoin Rally?

WRITTEN BY Mayur Sontakke, CFA, FRM

Ever since the news about Facebook’s (FB) cryptocurrency project broke, Bitcoin has rallied on the hope that Facebook’s entry in the space will help make cryptocurrencies mainstream. Facebook’s cryptocurrency will be called Libra and will be governed by an association with 28 founding members across industries.